focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraven House Capital Regulatory News (CRV)

Share Price Information for Craven House Capital (CRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.20
Bid: 0.15
Ask: 0.25
Change: 0.00 (0.00%)
Spread: 0.10 (66.667%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.20
CRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Loan Acquisition & Issue of Equity

28 May 2013 15:12

RNS Number : 7187F
Craven House Capital PLC
28 May 2013
 



28 May 2013

Craven House Capital Plc

("Craven House" or the "Company")

 

Loan Acquisition

Issue of Equity

 

The Company today announces that it has signed an agreement to acquire, at a small fraction of its nominal value, a distressed loan (the "Loan") in the 3 Star Green Isle Conference and Leisure Hotel in Dublin (the "Hotel").

 

The Hotel has 270 bedrooms, as well as conference and leisure facilities, and recently was independently valued at between €3.5m and €5m. Following the acquisition of the Loan, which is being acquired for a cash consideration of €0.7 million, Craven House will be the sole secured lender for the Hotel and will then lead a restructuring of the remaining unsecured creditors.

 

Under the original terms of the Loan, the Hotel was due to pay an annual interest charge of approximately €250,000 per annum. The directors of Craven House believe that the Hotel can be a profitable going concern and, post the restructuring, can generate more than sufficient cash-flow to service a significant annual interest payment to Craven House, resulting in a substantial increase in the Company's annual revenues.

 

Desmond Holdings Ltd ("Desmond"), the Company's Investment Manager, will lend the Company the €700,000 required to complete the transaction at a rate of 6% per annum (the "Desmond Loan"). The Desmond Loan is repayable after a period of two years and can also be converted into equity in Craven House (at a price of 1.25p per share) at Craven House's discretion.

 

Desmond is a substantial shareholder in the Company and Mark Pajak is a director and shareholder in Desmond. Accordingly, the Desmond Loan constitutes a related party transaction under AIM Rule 13. The independent directors of the Company, having consulted with Daniel Stewart & Company plc, the Company's nominated adviser, consider that the terms of the transaction are fair and reasonable as far as shareholders are concerned.

 

Mark Pajak, Acting Chairman, commented, "It is core theme of the Company's investing policy to acquire interests in cash generative assets. The directors believe that the Hotel is such an asset and has the ability, post-restructuring, to significantly increase the Company's revenues and cash flows; with the additional potential of capital appreciation through having acquired the Loan at a significant discount to the underlying asset value."

 

The Company also announces the issue of 730,000 new ordinary shares of 0.1p each in the share capital of the Company, at a price of 1.25p per ordinary share, in lieu of fees of £9,125 ("New Ordinary Shares"). Application has been made to the London Stock Exchange for the New Ordinary Shares and admission is expected to take place on 3 June 2013. The New Ordinary Shares will rank parri passu with the existing issued ordinary shares. 

 

Following the issue of the New Ordinary Shares, the Company's total issued share capital will consist of 592,695,959 Ordinary Shares with each share carrying the right to one vote. The Company has no Ordinary Shares held in treasury. The total of 592,695,959 Ordinary Shares may therefore be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

 

 

 For further information please contact:

 

Craven House Capital Plc:

 

www.cravenhousecapital.com

 

 

Alexandra Eavis

Non Executive Director & Company Secretary

 

Tel: 07590 831 323

 

 

Daniel Stewart & Company Plc:

(Nominated Adviser & Broker)

 

Antony Legge/James Thomas

Tel: 020 7776 6550

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFLSELITFIV
Date   Source Headline
18th Feb 20207:00 amRNSPlacing to raise $2m
13th Feb 20203:37 pmRNSTR-1: notification of major holdings
12th Feb 20202:05 pmRNSSecond Price Monitoring Extn
12th Feb 20202:00 pmRNSPrice Monitoring Extension
12th Feb 20207:00 amRNSPlacing to raise $1.9m
13th Jan 20207:00 amRNSCompletion of purchase of IIU, Inc. from LMFA
7th Jan 20202:03 pmRNSTR-1: Notification of major holdings
6th Jan 202010:54 amRNSResult of AGM
3rd Jan 20207:00 amRNSLoan Agreement with LMFA
2nd Jan 20207:00 amRNSPortfolio and NAV update
29th Nov 201910:57 amRNSTR-1: Notification of major holdings
28th Nov 20195:58 pmRNSAnnual Results for year ended 31 May 2019
25th Nov 20192:28 pmRNSTR-1: notification of major holdings
21st Nov 20191:08 pmRNSTR-1: notification of major holdings
20th Nov 20192:04 pmRNSTR-1: notification of major holdings
15th Nov 20192:37 pmRNSIssue of Equity
30th Oct 20193:56 pmRNSTR-1: notification of major holdings
21st Oct 20194:41 pmRNSSecond Price Monitoring Extn
21st Oct 20194:35 pmRNSPrice Monitoring Extension
17th Oct 20199:55 amRNSIssue of Equity
1st Oct 201911:15 amRNSTR-1: Form for notification of major holding
27th Sep 20192:18 pmRNSTR-1: Notification of major holdings
26th Sep 201911:52 amRNSPotential Acquisition
25th Sep 20194:41 pmRNSSecond Price Monitoring Extn
25th Sep 20194:35 pmRNSPrice Monitoring Extension
30th Aug 20195:18 pmRNSCraven House increases stake in LMFA
30th Aug 20197:00 amRNSIssue of Equity
22nd Jul 20194:56 pmRNSChange of Company Secretary, Issue of Equity
3rd Jul 201912:24 pmRNSYear-end Update and Financial Calendar
10th Jun 20195:17 pmRNSCraven House increases stake in LMFA
6th Jun 201912:22 pmRNSCraven House increases stake in LM Funding America
27th Feb 20195:15 pmRNSInterim Results
17th Jan 20191:54 pmRNSCompletion of sale of subsidiary
4th Jan 201911:22 amRNSResult of AGM and GM
20th Dec 20181:25 pmRNSPotential sale of subsidiary
12th Dec 20188:00 amRNSReduction in Capital Update
11th Dec 20184:34 pmRNSPosting of Annual Report and Notice of AGM
29th Nov 20181:36 pmRNSAnnual Results for year ended 31 May 2018
14th Nov 20187:00 amRNSAcquisition of shares in LM Funding America, Inc.
17th Oct 20188:13 amRNSBoard Change
24th Aug 20184:20 pmRNSResult of General Meeting
9th Aug 201810:02 amRNSNotice of General Meeting
28th Jun 20182:05 pmRNSSecond Price Monitoring Extn
28th Jun 20182:00 pmRNSPrice Monitoring Extension
11th Jun 20183:13 pmRNSSettlement of Legal Dispute
1st Jun 20182:49 pmRNSAcquisition of insurance broker in United States
24th Apr 20184:08 pmRNSDLC Holdings Update
20th Mar 20187:00 amRNSUpdate: DLC Holdings and Qeton
28th Feb 20187:00 amRNSInterim Results
7th Feb 20184:33 pmRNSFMCD Ltd partially repay Convertible Loan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.